Pathological control plasma with decreased and with

The kit is designed to control the correctness of in vitro determination of f. VIII activity in plasma of donors, in plasma of haemophilia A patients, in plasma of patients with thrombophilia with high f.VIII levels and in therapeutic preparations of cryoprecipitate and fresh frozen plasma (FFP). Plasma control pathological with reduced (about 20%) and with increased level of factor VIII (about 200%) is used for quality control of coagulation factor VIII activity determination by unified one-stage clotting method: in plasma of donors in plasma of patients with haemophilia A; in plasma of patients with thrombophilic conditions caused by high level of factor VIII activity; in therapeutic preparations of cryoprecipitate (factor VIII).

Set composition: plasma with 20% activity of factor VIII, lyophilically dried (1.0 ml) - 3 vials; plasma with 200% activity of factor VIII, lyophilically dried (1.0 ml) - 3 vials.